FactEvidence 1
produces眼科产品
No public evidence summary is available.
钛媒体 · 2026-10-02 10:17
View evidence
- Media钛媒体2026-10-02 10:17View source
Company
芳拓生物
Description
- Headquarters
- CN
Structure of 芳拓生物
芳拓生物
Company
8 connections
UpstreamSupply and dependency
ConstraintsRegulation and exposure
OwnProducts and technology
OwnershipInvestment and holdings
Relationship began
芳拓生物Company · 8 connections
Layer 1UpstreamSupply and dependency1
OwnershipInvestment and holdings4
OwnProducts and technology1
ConstraintsRegulation and exposure2
Relations
Arrows show the direction of the relationship. Filter to focus on a business area.
- Organization · 中国证监会Evidence 1Fact55%
View evidence
- Media钛媒体2026-10-02 10:17View source
- Product · 眼科产品Evidence 1Fact55%
View evidence
- Media钛媒体2026-10-02 10:17View source
- Geography · 苏州Evidence 1Fact55%
View evidence
- Media钛媒体2026-10-02 10:17View source
- Technology · AAV基因治疗Evidence 1Fact55%
View evidence
- Media钛媒体2026-10-02 10:17View source
- 奥博资本invests in →芳拓生物Company · 奥博资本Evidence 1Fact55%
View evidence
- Media钛媒体2026-10-02 10:17View source
- 泓元资本invests in →芳拓生物Company · 泓元资本Evidence 1Fact55%
View evidence
- Media钛媒体2026-10-02 10:17View source
- 博裕资本invests in →芳拓生物Company · 博裕资本Evidence 1Fact55%
View evidence
- Media钛媒体2026-10-02 10:17View source
- 红杉中国invests in →芳拓生物Company · 红杉中国Evidence 1Fact55%
View evidence
- Media钛媒体2026-10-02 10:17View source
Showing 1 to 8 of 8
Claims
Read the assertion alongside its sources. Expand a row to inspect the evidence.
FactEvidence 1
located in苏州
No public evidence summary is available.
钛媒体 · 2026-10-02 10:17
View evidence
- Media钛媒体2026-10-02 10:17View source
FactEvidence 1
usesAAV基因治疗
No public evidence summary is available.
钛媒体 · 2026-10-02 10:17
View evidence
- Media钛媒体2026-10-02 10:17View source
FactEvidence 1
Claims5.28 亿美元
No public evidence summary is available.
钛媒体 · 2026-10-02 10:17
View evidence
- Media钛媒体2026-10-02 10:17View source
FactEvidence 1
regulated by中国证监会
No public evidence summary is available.
钛媒体 · 2026-10-02 10:17
View evidence
- Media钛媒体2026-10-02 10:17View source
FactEvidence 1
Claims计划在香港上市
No public evidence summary is available.
钛媒体 · 2026-10-02 10:17
View evidence
- Media钛媒体2026-10-02 10:17View source
Showing 1 to 6 of 11
Market and valuation
Valuation data is available on Pro and Research.
Included in ProNot available: Company signals · Financials · Filings · Guidance